GDTC
CytoMed Therapeutics LtdCompany with tickers: GDTC
CIK
1873093
CUSIP
Y1R80M106
Shares Outstanding
11,828,435
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2023-03-31 | Loh Yuin Han | Director | Other | 0 |
| 2023-03-31 | Leong Mark Kei Wei | Director | Other | 0 |
| 2023-03-31 | Zeng Jieming | Director, CSO and CMO | Other | 589,239 |
| 2023-03-31 | Toh Keng Kiat | Director | Other | 0 |
| 2023-03-31 | Choo Chee Kong | Director, 10% Owner | Other | 2,559,482 |
| 2023-03-31 | Luk Lucas Tien Wee | Director, Chief Clinical Officer | Other | 92,563 |
| 2023-03-31 | Yew Chak Hua | Director | Other | 0 |
| 2023-03-31 | Tan Wee Kiat | Director, Chief Operating Officer | Other | 0 |
| 2023-03-31 | Wang Shu | 10% Owner | Other | 883,858 |
| 2023-03-31 | Glorious Finance Ltd | 10% Owner | Other | 4,653,604 |